No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Shanghai Haixin Group (600851.SH): has not yet deployed in the DeepSeek field.
According to Gelonghui on March 12, Shanghai Haixin Group (600851.SH) stated on the investor interaction platform that the company has not yet deployed in the DeepSeek field.
Haixin Group Unit Gets Registration, API Approval in China for Intubation Sedative
Express News | Shanghai Haixin Group: The company's Chairman Fei Minhwa has resigned.
Express News | Shanghai Haixin Group: The company's PE indicators are significantly higher than the Industry level.
Express News | Shanghai Haixin Group: The company's current production and operation activities are normal, and there is no significant information that should be disclosed but has not been disclosed.
